News

Driving a Stake Into Resurgent TB

See allHide authors and affiliations

Science  13 Jul 2001:
Vol. 293, Issue 5528, pp. 234-235
DOI: 10.1126/science.293.5528.234

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Eighty years after the first tuberculosis vaccine was developed from a bovine cousin of Mycobacterium tuberculosis, the bacterium that causes the disease, its efficacy has come into question. Health leaders have been saying they need a new vaccine; now a fascinating conjunction of events has led to trials of at least five new TB vaccines. But who will pay for them?